Board Dossier
President & CEO, Ardent Health Partners · FAH Chair-Elect & Secretary · FAH Chair-Elect Since 2026
ModerateArdent Health Partners operates 30 acute care hospitals across six states under a controlled company structure dominated by private equity and foreign sovereign wealth.
| Metric | Value |
|---|---|
| Hospitals | 30 acute care |
| Care Sites | ~280 |
| States | TX, OK, NM, NJ, ID, KS |
| Revenue FY2024 | $5.97B |
| NYSE | ARDT (IPO July 2024) |
| Employees | ~26,000 |
| FAH Role | Chair-Elect and Secretary |
| FAH Chair-Elect Since | 2026 |
Ardent is a controlled company under NYSE rules. EGI, the investment firm founded by the late Sam Zell, holds majority control and dictates board nominations.
| Entity | Stake | Control Rights |
|---|---|---|
| Equity Group Investments (EGI) | ~58–62% | Right to nominate majority of directors and designate Chairman |
| Pure Health Holding (UAE) | ~21–26% | Board observer rights; no board seat |
| Ventas REIT | ~3–7% | Right to nominate one director |
| Public stockholders | ~10–15% | Limited voting power |
Pure Health Holding PJSC (ADX: PUREHEALTH) is linked to Alpha Dhabi Holding and International Holding Company (IHC), both connected to Abu Dhabi’s ruling family. ADQ, an Abu Dhabi sovereign wealth fund, consolidated multiple entities within Pure Health in January 2023 including Abu Dhabi Health Services (SEHA) and National Health Insurance (Daman).
Pure Health acquired its 26.05% stake for $500 million in a transaction announced September 2, 2022 and completed in early 2023.
Ardent leases 10 of its 30 hospitals from Ventas under a master lease expiring in 2035, generating $145.9 million in annual rent expense in 2023.
| Detail | Value |
|---|---|
| Hospitals leased from Ventas | 10 of 30 |
| Master lease expiration | 2035 |
| Annual rent expense (2023) | $145.9M |
| 2022 sale-leaseback | 18 medical office buildings sold to Ventas for $204M |
| Ventas cross-acceleration | Default provisions and purchase options on personal property |
| Rent escalators | Contractual annual increases |
Bonick’s compensation actually paid in 2024, including equity fair value, was $18.7 million. His median worker earned $50,653.
| Metric | Amount |
|---|---|
| Total compensation (summary table) | $6,939,253 |
| Compensation actually paid (equity fair value) | $18,696,908 |
| Base salary 2024 | $1,060,485 |
| Base salary 2025 | $1,076,000 |
| CEO-to-median worker ratio | 137:1 |
| Median worker salary | $50,653 |
| March 2026 equity grant | 195,316 shares |
| Organization | Role | Period |
|---|---|---|
| Ardent Health Partners | President and CEO | 2020–present |
| PhyMed Healthcare Group | CEO | 2017–2020 |
| Community Health Systems | Division President | 2011–2017 |
| Ardent Health Services | CEO Hillcrest Medical Center; VP Operations | 2004–2011 |
| Hillcrest HealthCare System | Various leadership roles | 1997–2004 |
Bonick contributed $5,000 personally to the FAH PAC in the 2024 cycle and an additional $5,000 to the Ardent Health Services PAC.
| Recipient | Amount | Cycle |
|---|---|---|
| FAH PAC | $5,000 | 2024 |
| Ardent Health Services PAC | $5,000 | 2024 |